Widely studied markers, such as microsatellite stability (MSS), KRAS, CDX2 (Caudal-type homeobox 2), and CK20, are essential in CRC diagnosis and therapeutic planning [7,8,9]. This evidence concerns the gene KRAS and colorectal carcinoma.